News from Montana BioScience Alliance
$Account.OrganizationName
Montana BioScience Alliance Newsletter )
June 2009
In This Issue:
  • Member News
  • Universities
  • Montana News
  • Industry News
  • What's Happening?
  • Events Calendar
  • Classifieds


  • Summer is here!

    __________________

    Please welcome our newest member:

    Kurt Burgess
    Business Development/Corporate Services
    Jon E. Block Ph.D. Incorporated
    San Francisco, California

    Please welcome our Montana Bioscience Alliance Intern:

    Shaun Hoover

    Shaun is a senior at Montana State University- Billings. He will graduate in December with a Bachelor of Science in Business Administration with an emphasis in Marketing and Management. He has already mastered the website and the newsletter for the Montana BioScience Alliance.

    Also, don't forget to REGISTER HERE for the Annual Meeting on July 16th and 17th!


    Member News

    Genectar to Occupy New Biotech Lab

    Genectar will occupy a new biotechnology laboratory in Columbia Falls. Commercial grade utilities were placed on the 9.5 acre building site. A roof will be completed in June 2009.

    Genectar President Thomas M. Brown presented "Pigmentation Genetics and the Eye of a Moth" to Flathead Community College Seminar Series on April 23, 2009 and will present "A candidate golden gene (slc24a5) from a Lepidopteran, Bombyx mori by Comparative Genomics" to the Third Arthropod Genomics Conference in Kansas City from June 11- 13, 2009.

    ________________________

    Summit Corporate Services and Mederi Therapeutics Finalize Multi-Year Outsourcing Agreement

    BOZEMAN, MONTANA (June 1, 2009) - Summit Corporate Services, Inc., a leading provider of customer service and supply chain solutions for the medical device and pharmaceutical industries, and Mederi Therapeutics Inc., a medical device company whose first two products deliver proprietary minimally invasive treatments for GERD (gastroesophageal reflux disease) and FI (fecal incontinence), have finalized an agreement for Summit to provide customer service, order processing & fulfillment, product support, inventory management, distribution, invoicing, collections and logistical support for Mederi's Stretta® and Secca® product lines.

    Secca® is an innovative treatment option for patients suffering from FI. The Secca® procedure involves no implants, incisions or stitches and is performed in an outpatient setting. Stretta® is a minimally invasive treatment for patients suffering from GERD. Studies have shown that Stretta® produced significant improvement in GERD symptom scores for heartburn, patient satisfaction and quality of life while eliminating or decreasing the need for medication. Similar studies have shown sustained benefits over 4 years of follow up. Additional information on the Secca® and Stretta® treatments is available online at www.mederitherapeutics.com.

    Summit Corporate Services specializes in providing customized outsourcing solutions to medical companies who market highly complex products. Summit's extensive service options include: customer service, product support, order processing and fulfillment, inventory management, distribution, logistics, billing, collections, quality assurance and subject recruitment. Summit's outsourcing solutions are applicable to all industries and have helped numerous clients, including Stryker Spine, Cardo Medical, Bone Support, and Wound Care Technologies control costs and improve efficiencies. Summit Corporate Services is headquartered in Bozeman, Montana. Additional information is available at www.summit corporate.com.
    ________________________

    Billings Clinic Research Center

    Billings Clinic Research Center was chosen one out of six sites nationwide for a Phase I investigational oral drug for multiple sclerosis. This new class of drugs is designed to block T and B cell migration from the thymus and lymph nodes, decreasing circulating blood lymphocyte counts, suppressing one part of the immune function.

    Universities
    msu pic

    Cover of Journal shows cell infected by virus first viewed by MSU scientists
    By MELYNDA HARRISON

    The June cover of the Journal of Virology features a photograph of the unusual effects on a cell infected by a virus. Montana State University researchers were the first to view the virus, which they collected from a boiling, acidic spring in Yellowstone.

    The article linked with the cover photograph describes the researchers' findings about the life cycle of the virus Sulfolobus turreted icosahedral virus (STIV). No one has seen STIV replicate within a host cell prior to the work done by MSU scientists.

    "What is really surprising is how the virus gets out of the infected cell," said MSU virologist Mark Young.

    STIV forms a pyramid-like projection on the surface of the cell.

    "It looks just like the glass pyramid in front of the Louvre," Young said.

    Understanding how particular viruses assemble and replicate often leads to new uses for the virus. For example, laboratories run by Young and chemist Trevor Douglas at MSU have demonstrated that viruses can be used for beneficial purposes ranging from creating smart drug delivery and imaging systems to making viruses act as nano-containers for making high performance magnetic materials for the computer industry.

    Susan Brumfield, Vincent Ruigrok, Peter Suci, Douglas and Young of MSU and Alice Ortmann of the University of South Alabama, Mobile, investigated the effects of the virus on its host cell.

    The pyramid-like projections have not been documented in any other host-virus system, according to the paper's authors. The structures are thought to be at sites where the virus' progeny are released from the cell.

    The STIV virus was collected from Yellowstone National Park and brought back to a laboratory at MSU. The extreme environment that STIV lives in had to be replicated in order to keep the virus alive for study.

    "Essentially we had to recreate Yellowstone in the lab," said Young.

    The virus and its host cells continued to grow in an acid solution that mimics the water of Yellowstone hot springs and in specialized incubators that kept the virus at a toasty 176 degrees Fahrenheit. Then, the scientists were able to view the virus within its host using a high power electron microscope.

    "We can look at the virus inside the cell for the first time," said principle author, Brumfield. "We could watch the construction of the virus in the cell and see how it released itself from the host cell."

    "It's really an engineering feat," Young added. "It's kind of like building a house, and we saw it do that inside the cell for the first time."

    "We'll continue to look in Yellowstone, and places like Yellowstone around the world," said Young. "Understanding viruses is fundamental work."

    The Journal of Virology is one of the top three (of 25) virology journals according to the Institute for Scientific Information.

    Contact Mark Young at (406) 994-5158 or myoung@montana.edu

    ____________________________

    UM Offers Cancer Biology Class This Summer

    UM will offer a new, five-week introductory course on cancer this summer that is open to students in all majors. Introduction to Cancer Biology will provide an overview for undergraduate students interested in an accessible course on cancer and its treatment and prevention.

    The three-credit course has no prerequisites and satisfies the lecture portion of the natural science general education requirement. It will be held from 1 to 3 p.m. Monday through Thursday during the second summer session, June 29-July 30, in air-conditioned Skaggs Building Room 117.

    The class will be taught by course coordinator Mark Pershouse. Additional faculty members will teach sections on cancer epidemiology, familial and non- familial cancers, and the fundamentals of cancer treatment. The final lectures on the latest options in cancer treatment will be given by Dr. Patrick Beatty, president of the Montana Cancer Institute, a UM-St. Patrick Hospital and Health Sciences Center collaboration.

    To register, visit Cyberbear. The course registration number is 51424. For more information, call Pershouse at 406-243-4769 or e- mail mark.pershouse@umontana.edu

    Montana News

    Congratulations to the Montana Cancer Center Staff!

    The Montana Cancer Center in Missoula was the recipient of the 2008 Commission on Cancer Outstanding Achievement Award. This achievement is indicative of the outstanding efforts of the Montana Cancer Center Staff and they're commitment to provide patient with quality cancer care.

    ____________________________

    Reporter's Notebook: Miles City Scientist's Work Still Paying Off
    By DIANE COCHRAN - Billings Gazette

    What would Dr. Maurice Hilleman do?

    That question has almost certainly crossed the minds lately of people who know of Hilleman, a skilled scientist who invented some 40 vaccines, including eight of the 14 childhood vaccines commonly used in the United States.

    How would Hilleman, who died in 2005 at age 85, react to the H1N1 strain of influenza that surfaced last month in Mexico?

    Lab skills

    Could he have put his awesome laboratory skills to work on a vaccine for the new bug, also called the swine flu, the way he did in 1957 when he logged nine 14-hour days in a row to identify the Hong Kong flu?

    That particular influenza ended up killing 69,000 Americans, but another 40 million got vaccines based on Hilleman's work.

    Despite his immeasurable influence on public health - news accounts published at the time of his death put into the millions the number of lives his work has saved - Hilleman is relatively unknown.

    "Among scientists, he is legend," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told the Washington Post in 2005. "But to the general public, he is the world's best- kept secret."

    Even Montanans, who take pride in keeping tabs on locals who splash big in the wider world, don't seem to know about Hilleman.

    Yep. He was one of us.

    Maurice Ralph Hilleman was born Aug. 30, 1919, in Miles City. His mother and twin sister died during the birth, and he and his older siblings were raised on a family member's farm.

    CLICK HERE for the complete story on the first person to be indcuted into the Montana Bioscience Hall of Fame.
    ____________________________

    Entrepreneurship Center receives grant
    By JOHN CRAMER - Ravalli Republic

    Funding for the proposed the Ravalli Entrepreneurship Center continued to solidify Thursday with the awarding of a $200,000 federal grant toward construction of a wastewater lift station.

    The Montana Department of Commerce on Thursday announced the Community Development Block Grant- Economic Development funds have been approved for the city of Hamilton.

    The city will provide the money to the Ravalli County Economic Development Authority for construction of a sewerage lift station for the REC.

    The city will own the lift station, which is a key part of infrastructure needed for economic development.

    The lift station also will provide sewer services for a senior housing cooperative proposed by the Ravalli County Council on Aging, as well as for new housing in the area.

    The REC, which has been planned for more than a decade, will be an incubator that offers laboratories and office space to promote small start-up technology businesses.

    The county's growing bio-technology and research industry already employs hundreds of workers at GlaxoSmithKline and Rocky Mountain Laboratories, which might open branches in the REC.

    The REC is to be built on Old Corvallis Road on four acres of the Council on Aging's property.

    Ground breaking began this spring and construction will be completed later this year.

    The picture below:(From left) Ravalli County Commissioner Kathleen Driscoll, Inga Rudbach, Ravalli County Economic Development Authority Chairman Monte Drake and Hamilton Mayor Jerry Steele wielded golden shovels at the ground breaking.

    The facility will have three full-time equivalent jobs, while the Council on Aging and Senior Housing Cooperative will create five full-time positions.

    "Many partners are contributing significantly to this project," Anthony Preite, state commerce department director, said in a statement. "That sense of teamwork and cooperation to leverage sources for a common cause really gets work done."

    The REC project will cost $3.2 million with $350,000 of that going to the lift station construction.

    The REC also will be funded by a $1.6 million grant from a U.S. Economic Development Administration. The Ravalli County Council on Aging and the Bessenyey family will donate land valued at $1,021,440.

    The REC's other funding includes a loan from Ravalli County Bank for $65,000, a loan for $135,000 from Economic Development Authority's Revolving Loan Fund, $59,000 in equity from the authority, a loan from Montana Technology Enterprise Center for $25,000 and other bank loans for $116,000.

    Montana's CDBG-ED program is intended to promote economic development by helping Montana's private sector to create and retain jobs for low- and moderate- income people.

    The program receives funding from the CDBG program funded by the U.S. Department of Housing and Urban Development.

    The REC will provide technical assistance, business coaching, mentoring, advisory boards, networking opportunities, access to capital programs, market information and office space to local businesses.

    The Economic Development Authority projects the REC will create 253 jobs from the start up and encourage more than $11 million in private investment over the next 10 years.

    About 60 percent of the REC facility will be leasable space, or a maximum of 18 offices. When businesses start with the REC program, they will lease those spaces until they can sustain themselves.

    ____________________________

    NIH Approves Master Plan for Rocky Mountain Laboratories

    The National Institutes of Health (NIH) has approved a 20-year Master Plan to guide the development of its scientific research campus at Rocky Mountain Laboratories in Hamilton. The approval comes after three years of planning, consideration of public input and the completion of an Environmental Impact Statement.

    The Master Plan option approved is the low-growth proposal that NIH preferred in its draft document. That option calls for RML employment to reach about 427 people by 2025; RML presently employs about 395 people, including government employees and contractors.

    Other options considered were no growth and maximum capacity.

    "Now we begin applying the plan to new activities on the RML campus," said Ron Wilson, director of the Division of Facilities Planning for the NIH. He will work with NIH and RML personnel to plan initial activities, but says likely high priorities include campus landscaping, expansion of a security fence and improvements to roads and parking.

    Wilson said the Master Plan already has helped prioritize one upcoming RML project, renovation of a building that for many years housed the campus boiler plant. That building will become a new biosafety level-2 laboratory, with support and office space, in RML's central building complex known as The Quad.

    Formal approval of the Master Plan was announced in a Record of Decision (ROD) published Tuesday in the Federal Register. Copies of the ROD are available in the RML Visitor's Center and on the Internet at http://edocket.access.gpo.gov/2009/E9-10290.htm.

    Along with some growth in personnel, the Master Plan addresses the potential for land acquisition to the north of RML's existing boundary and for limited construction of new administrative and research spaces.

    All future construction and renovation projects must first meet NIH's requirements for programmatic need and must secure federal funding.

    The ROD states that the Master Plan option chosen "is intended to be a strategic tool for the efficient allocation of campus resources, the orderly accommodation of future growth and the creation of an environment which is both functionally and aesthetically conducive to accomplishing the RML mission," which is scientific research. "New development would be responsive to the context of adjacent neighborhoods or developments."

    The U.S. Department of Health and Human Services (HHS), which oversees NIH, requires that all NIH facilities have a Master Plan. RML is a component of the NIH's National Institute of Allergy and Infectious Diseases (NIAID), with headquarters in Bethesda, MD.

    Wilson is planning to travel to Hamilton from Bethesda in June to discuss the Master Plan with local government leaders, interested parties and RML employees.

    ____________________________

    11th Annual Montana Neuroscience Retreat
    By ANN MARIE QUINN

    When most people think of Montana, they think of a perfect day casting in the river, skiing in deep powder, or hiking for beautiful views. It might come as a surprise that Montana has become a first class place for neuroscience too, as shown last weekend when over 70 neuroscientists gathered for a retreat at Seeley Lake. The 11th annual Montana Neuroscience Retreat was a mecca for brain researchers across the state, including attendees from the Center for Structural and Functional Neuroscience at the University of Montana, the McLaughlin Institute, the Department of Cell Biology and Neuroscience at Montana State University and representatives from companies that develop products for brain research. Dr. Matthew Ames, Director of Molecular Pharmacology from the Mayo Clinic said, "They've established a world-class neuroscience research program in Montana. It's brought a whole new scope of outstanding science to the universities in Montana, and added to the economic climate."

    The highlight of the meeting was the Saturday night poster session. Awards were given for the best posters. April Johnston, a Research Specialist and recent graduate of MSU Cell Biology and Neuroscience, was one of the award winners. "My poster is about research I did while working in Charlie Gray's lab at MSU, where I learned how to record electrical activity in neurons. The techniques I learned at MSU gave me the skills I needed to land my first job as a scientist. I'm excited to be learning more electrophysiology techniques to study the brain, including patch clamping." April's new boss, Josh Lawrence said, "I can't believe I was able to find a person right out of college with April's skills. I am so lucky to have April in the lab. She's already getting some great results!" Drago Guggiana-Nilo, a Cell Biology and Neuroscience student from MSU and Alana White, a graduate student from University of Montana also won awards for their posters. Winners took home Apple ITouch prizes donated by Leeds Instruments, a corporate sponsor of the annual event.

    The primary goals of the retreat are to bring Montana neuroscientists together to share research results and to foster collaborations that will advance neuroscience research in the state. Mike Kavanaugh, the University of Montana Director of Neuroscience said, "I think scientists really love to share their data, and when a discovery is made, that's almost what we live for, to find something that is going to have an impact on the field especially if it is something that might potentially impact human health."

    The meeting featured seminars on Saturday and Sunday. Deb Cabin reported on the expansion at the McLaughlin Institute, and plans to recruit new neuroscientists. Thom Hughes, from MSU spoke about the numerous biotech companies that impact neuroscience research in Bozeman, including Neuralynx, Gray Matter, Montana Molecular, Resonon, AdVR and Fluorescence Innovations. He pointed out the important role these companies play in providing job opportunities for students graduating from the University of Montana and MSU neuroscience programs. Chris Comer, a neuroscientist and the incoming Dean of Arts and Sciences at the University of Montana, presented his work showing how sensorimotor integration in the brain of naked mole rats can provide clues about how to build the next lunar explorer. Sensorimotor integration translates sensory information in the brain into behavioral responses, and can potentially inform the development of new robotics for brain-operated prosthetic devices too. Keynote addresses were given by Jeffrey Rothstein from Johns Hopkins University and Randy Blakely, the Allan D. Bass Professor of Pharmacology and Psychiatry from Vanderbilt University. Dr. Blakely talked about his recent discoveries that provide new insights into the molecular mechanisms of ADHD and the drugs used to treat this disorder. Phil Beske, a graduate student at the University of Montana who studies the underlying effects of stroke on the brain, explained how the enzyme NADPH oxidase plays a key role in learning and memory and described his discovery that overactivity of the enzyme, that occurs after a stroke, can contribute to cell death.

    Rain fell over the weekend but did not dampen the enthusiasm for brain research or the camaraderie. New ideas were hatched, collaborations were formed and everyone left the meeting looking forward to the next discovery and the opportunity to share it.

    Industry News

    Algal Biofuels Roadmap Currently Under Construction

    On December 9 and 10, 2008, the U.S. Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy (EERE), Office of the Biomass Program sponsored a technology roadmap workshop to stimulate the development of commercial algal biofuels. The workshop successfully brought together the interdisciplinary expertise of more than 200 scientists, engineers, research managers, industry representatives, academics, lawyers, financiers, and regulators to fully discuss the promise and challenges of a commercial algal biofuels industry. Workshop participants insight was captured on a range of technical challenges related to topics such as: · Algal Biology · Cultivation · Harvesting/Dewatering · Extraction/Fractionation · Conversion to Fuels · Systems Integration · Siting & Resources · Regulation & Policy In discussions throughout the workshop, industry, academic, and national lab partners suggested that to develop algal biofuels, the coordination and support of fundamental research, infrastructure development, technology deployment, and information management at a national level by DOE will be necessary. A complete workshop summary is now available at www.orau.g ov/algae2008pro and the results of the workshop are being used to develop a technology roadmap, which is expected to be published Summer/Fall 2009.

    ________________________

    NIAID and the Economic Recovery Act

    To spark a recovery of the U.S. economy, Congress passed a $787 billion stimulus package. President Barack Obama signed the American Recovery and Reinvestment Act (ARRA) of 2009 into law on February 17.

    Congress and the President are looking to create and save jobs, jump-start the economy, and build the foundation for long-term economic growth.

    The biomedical research enterprise has a major role to play: NIH received an astounding 34 percent increase to its budget in two-year stimulus funds, a striking act of generosity and confidence on the part of our elected leaders. Most of this money is slated to go to universities and other research institutions around the country.

    The governments recognition of the importance of biomedical and behavioral research will enable NAID to uncover new knowledge that will improve public health while moving the economy down the road to recovery.

    NIAID is responding to the challenge by awarding hundreds of high-quality peer-reviewed grants so the stimulus money can boost the economy quickly.

    President Obama also emphasized the need for an effective response, "What I will need from all of you is unprecedented responsibility and accountability.

    Follow the link below to read how NIH and NIAID are meeting the President's challenge and find important information for investigators.

    NAID Economic Recovery Act

    What's Happening?

    Sharon Peterson participated in the 2009 Biotechnology Industry Organization Legislative Fly-In on March 31 - April 1 2009. The Fly-in began with a 4:30 PM briefing on BIO's key legislative issues before the U.S. Congress. Following the briefing, BIO hosted a welcoming reception at 6:00 PM. The following morning, Wednesday, April 1st began with an 8:00 AM plenary breakfast on Capitol Hill. Russ Sullivan and Kathy Koch from the Senate Finance Committee spoke. Afterwards, participants were organized into small groups for individual meetings with legislators and key staff. The plenary luncheon featured Senator Arlen Specter (R-Pennsylvania.)
    ________________________

    Rob Bargatze, Sharon Peterson and Chuck Richardson represented the Montana BioScience Alliance at the 2009 BIO International Convention in Atlanta Georgia, May 18-21. It was a busy convention with almost 15,000 attendees. We had a 10 x 10 booth on the trade show floor and are very grateful to the organizations who sent us material and to the Governor's office for funding the booth. The three of us were kept busy, attending Council of State Bioscience Associations meetings, manning the booth with a drawing for a custom made fly rod, and attending the many meetings at the convention. A couple of the highlights of the convention were the keynote speech by Sir Elton John and a health care policy keynote featuring Sen. Thomas Daschle (D- SD): William Frist M.D. former Majority Leader of the U.S. Senate: Gov. Howard Dean (D-VT): and Mr. Karl Rove, Senior Advisor and Deputy Chief of Staff to former President George W. Bush.

    Next year's convention is well into the planning stages and will be in Chicago May 3-6, 2010. Save the date on your calendar and plan to join us.
    ________________________

    HB 572 - Authorization for a SBIR/STTR matching grant program for Montana was introduced in the Montana House of Representatives by Rep. JP Pomnichowski on February 20, 2009. After hearings in the House and Senate Business and Labor Committees, the bill passed both the House and Senate and was signed by the Governor, April 15, 2009. Special thanks to Senator Kim Gillan for requesting this vital legislation and carrying the bill in the Senate, Rep. Pomnichowski for her strong support and great work on the bill and Anne Marie Quinn for representing the Alliance in this effort.

    Included in HB 2 - the appropriations bill - is $2.5 million for bio-medical research. The Montana Department of Commerce will be issuing grant applications in the near future.

    Events Calendar



    June 26 and July 10, 2009
    Pharmacy Open House
    Prospective pre-pharmacy students or students who will be applying for the professional pharmacy program - You are invited to a Skaggs School of Pharmacy open house.
    Please call 406-243-4656 if you plan on attending an open house. If you would also like to schedule a campus tour, please call The University of Montana Enrollment Services office at 406-243-6266.

    July 8-9, 2009
    Northwest Research and Education Institute Event
    Certified HIPAA
    Professional Training
    Billings, MT
    Call 406.237.5306 to Register

    July 17, 2009
    Montana BioScience Alliance Annual Meeting
    Hamilton, MT
    Register Here

    July 23-24, 2009
    Join us for the Rocky Mountain Valve Symposium
    Aortic Dissection

    August 14, 2009
    McLaughlin Research Institute
    Scientific Advisory Committee meeting and Workshop
    Heritage Hall, MSU-GF

    September 10-11, 2009
    Northwest Research and Education Institute Event
    2nd Annual
    Chiari Conference
    Billings, MT

    September 14-26, 2009
    13th Annual
    MT Regional
    Sleep Seminar
    Billings, MT
    INFORMATION &
    REGISTRATION


    September 16-18, 2009
    Save the Date!
    Western Region COBRE-INBRE Scientific Conference
    Big Sky Resort Big Sky, Montana (www.bigskyresort.com)
    All Investigators, Staff, and Students are welcome
    Program details will be posted on the MT INBRE website (http://inbre-brin.montana.edu) by late spring. For more information or questions, please call or e- mail Mark Quinn for COBRE (406-994-4707, mquinn@montana.edu) or Ann Bertagnolli for INBRE (406-994-5214 or abertagnolli@montana.edu).

    Classifieds

    There is now a classifieds section on the Montana Bio website, in the resources section! Please send information to Sharon at sharonpeterson@bresnan.net .

    Help Wanted
    Summit Corporate Services, an outsource service provider to the medical device industry, is seeking a detail-oriented, upbeat, dependable individual to join our team. This position is the Account Lead responsible for bridging the gap between sales reps, hospitals, and the device manufacturers, so professional communication skills are essential. Responsibilities will include: order processing and fulfillment, inventory management, and Quality Assurance document review. Individuals applying should have excellent computer skills with attention to detail and accuracy. Summit provides a relaxed but productive work environment, great benefits, and wages DOE. Please submit your resume in confidence to HR@summitcorporate.com or fax to (406) 556-1322.

    The Montana BioScience Alliance is located on the Downtown Campus of Montana State University-Billings, through the generous support of the University.

    Quick Links...

    phone: 406-896-5876